Clinical Trial

EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol

Recruiting
View on ClinicalTrials.gov →
Summary
MicroPort (MPO) is conducting this PMCF study to evaluate the safety and effectiveness of its EVOLUTION® Revision Tibial System and EVOLUTION® Revision STEMMED CS Femur with the EVOLUTION® MP CS Tibial Insert. This type of study is required by regulatory authorities for all devices that have been approved in Europe to evaluate the medium and long-term clinical evidence.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-16.
Trial Details
NCT Number NCT06142669
Lead Sponsor MicroPort Orthopedics Inc.
Conditions Joint Diseases
Enrollment 45 participants
Start Date 2023-10-31
Primary Completion 2036-06 (estimated)
Study Completion 2036-12 (estimated)
Updated on ClinicalTrials.gov 2024-01-22